Ian Read | Community Health

Ian Read is a Scottish-American businessman who served as the Chairman and CEO of Pfizer, one of the world's largest pharmaceutical companies, from 2010 to 2020. During his tenure, Pfizer acquired Wyeth for $68 billion in 2009 and Hospira for $17 billion in 2015. Read's leadership was marked by significant revenue growth, with Pfizer's annual revenue increasing from $48 billion in 2010 to $51.8 billion in 2019. However, his tenure was also marked by controversy, including criticism over Pfizer's tax inversion deal with Allergan in 2015, which was later canceled due to regulatory scrutiny. Read has been a vocal advocate for the pharmaceutical industry, serving as the Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) from 2015 to 2016. As the pharmaceutical industry continues to evolve, Read's legacy and impact on the industry will likely be debated by experts and critics alike, with some arguing that his leadership prioritized profits over patients, while others see him as a visionary who navigated the complex landscape of global healthcare.